Tag Archive | Refinitiv

US: PrEP use to transition from ‘Truvada’ to ‘Descovy’ within year

US: PrEP use to transition from ‘Truvada’ to ‘Descovy’ within year

(Reuters) The US Food and Drug Administration on Thursday approved Gilead Sciences Inc’s Descovy to reduce the risk of [HIV infection]. The approval does not include use of the drug by women to prevent HIV infection. Descovy, a combination drug, was approved in 2016 to treat people already infected with HIV. It contains a newer […]